676 research outputs found

    Assessing population impacts of toxicant-induced disruption of breeding behaviours using an individual-based model for the three-spined stickleback

    Get PDF
     This is the author accepted manuscript. The final version is available from Elsevier via the DOI in this recordThe effects of toxicant exposure on individuals captured in standard environmental risk assessments (ERA) do not necessarily translate proportionally into effects at the population-level. Population models can incorporate population resilience, physiological susceptibility, and likelihood of exposure, and can therefore be employed to extrapolate from individual- to population-level effects in ERA. Here, we present the development of an individual-based model (IBM) for the three-spined stickleback (Gasterosteus aculeatus) and its application in assessing population-level effects of disrupted male breeding behaviour after exposure to the anti-androgenic pesticide, fenitrothion. The stickleback is abundant in marine, brackish, and freshwater systems throughout Europe and their complex breeding strategy makes wild populations potentially vulnerable to the effects of endocrine disrupting chemicals (EDCs). Modelled population dynamics matched those of a UK field population and the IBM is therefore considered to be representative of a natural population. Literature derived dose-response relationships of fenitrothion-induced disruption of male breeding behaviours were applied in the IBM to assess population-level impacts. The modelled population was exposed to fenitrothion under both continuous (worst-case) and intermittent (realistic) exposure patterns and population recovery was assessed. The results suggest that disruption of male breeding behaviours at the individual-level cause impacts on population abundance under both fenitrothion exposure regimes; however, density-dependent processes can compensate for some of these effects, particularly for an intermittent exposure scenario. Our findings further demonstrate the importance of understanding life-history traits, including reproductive strategies and behaviours, and their density-dependence, when assessing the potential population-level risks of EDCs.Syngenta LtdBiotechnology and Biological Sciences Research Council (BBSRC

    Interactive effects of inbreeding and endocrine disruption on reproduction in a model laboratory fish

    Get PDF
    This is the final version of the article. Available from Wiley via the DOI in this record.Inbreeding depression is expected to be more severe in stressful environments. However, the extent to which inbreeding affects the vulnerability of populations to environmental stressors, such as chemical exposure, remains unresolved. Here we report on the combined impacts of inbreeding and exposure to an endocrine disrupting chemical (the fungicide clotrimazole) on zebrafish (Danio rerio). We show that whilst inbreeding can negatively affect reproductive traits, not all traits are affected equally. Inbreeding depression frequently only became apparent when fish were additionally stressed by chemical exposure. Embryo viability was significantly reduced in inbred exposed fish and there was a tendency for inbred males to sire fewer offspring when in direct competition with outbred individuals. Levels of plasma 11-ketotestosterone, a key male sex hormone, showed substantial inbreeding depression that was unaffected by addition of the fungicide. In contrast, there was no effect of inbreeding or clotrimazole exposure on egg production. Overall, our data provide evidence that stress may amplify the effects of inbreeding on key reproductive traits, particularly those associated with male fitness. This may have important implications when considering the consequences of exposure to chemical pollutants on the fitness of wild populations.Thanks to NERC's Post Genomics & Proteomics Programme NE/F0077871/1 and AstraZeneca's Safety, Health and Environment Research Programme for funding this work. We thank Alexander Scott (11-ketotestosterone radioimmunoassay) at the Centre for Environment, Fisheries and Aquaculture Science, Jan Shears and Luanne Wilkes at University of Exeter, Gareth Readman, Vicki Cammack, Kate Hurd and Yohanna Glennon at Brixham Environmental Laboratory for their assistance

    Quantification of finfish assemblages associated with mussel and seaweed farms in southwest UK provides evidence of potential benefits to fisheries

    Get PDF
    This is the final version. Available on open access from Inter-Research Science Publisher via the DOI in this recordLow trophic aquaculture, including shellfish and seaweed farming, offers a potentially sustainable food source and may provide additional environmental benefits, including the creation of new feeding, breeding and nursery areas for fish of commercial and ecological importance. However, quantitative assessments of fish assemblages associated with aquaculture sites are lacking. We used pelagic baited remote underwater videos (BRUVs) and hook and line catches to survey summer fish assemblages at 2 integrated blue mussel Mytilus edulis and kelp (predominantly Saccharina latissima) farms in southwest UK. We recorded at least 11 finfish species across the surveys, including several of commercial importance, with farmed mussels and/or kelps supporting significantly higher levels of abundance and richness than reference areas outside farm infrastructure. Farmed kelp provided temporary habitat due to seasonal harvesting schedules, whereas farmed mussels provided greater habitat stability due to overlapping interannual growth cycles. Stomach content analysis of fish caught at the farms revealed that some low trophic level species had high proportions of amphipods in their stomachs, which also dominated epibiont assemblages at the farms. Higher trophic level fish stomachs contained several lower trophic level fish species, suggesting that farms provide new foraging grounds and support secondary and tertiary production. Although not identified to species level, juvenile fish were abundant at both farms, suggesting potential provisioning of nursery or breeding grounds; however, this needs further verification. Overall, this study provides evidence that shellfish and seaweed aquaculture can support and enhance populations of commercially and ecologically important fish species through habitat provisioning.Worshipful Company of FishmongersCentre for Environment, Fisheries and Aquaculture Science (Cefas)Marine Biological AssociationNatural Environment Research Council (NERC)University of ExeterUKR

    Factors Determining the Susceptibility of Fish to Effects of Human Pharmaceuticals

    Get PDF
    This is the final version. Available on open access from the American Chemical Society via the DOI in this recordThe increasing levels and frequencies at which active pharmaceutical ingredients (APIs) are being detected in the environment are of significant concern, especially considering the potential adverse effects they may have on nontarget species such as fish. With many pharmaceuticals lacking environmental risk assessments, there is a need to better define and understand the potential risks that APIs and their biotransformation products pose to fish, while still minimizing the use of experimental animals. There are both extrinsic (environment- and drug-related) and intrinsic (fish-related) factors that make fish potentially vulnerable to the effects of human drugs, but which are not necessarily captured in nonfish tests. This critical review explores these factors, particularly focusing on the distinctive physiological processes in fish that underlie drug absorption, distribution, metabolism, excretion and toxicity (ADMET). Focal points include the impact of fish life stage and species on drug absorption (A) via multiple routes; the potential implications of fish’s unique blood pH and plasma composition on the distribution (D) of drug molecules throughout the body; how fish’s endothermic nature and the varied expression and activity of drug-metabolizing enzymes in their tissues may affect drug metabolism (M); and how their distinctive physiologies may impact the relative contribution of different excretory organs to the excretion (E) of APIs and metabolites. These discussions give insight into where existing data on drug properties, pharmacokinetics and pharmacodynamics from mammalian and clinical studies may or may not help to inform on environmental risks of APIs in fish.ServierEuropean Union Horizon 2020European Federation of Pharmaceutical Industries and Association

    Assessing risks and mitigating impacts of harmful algal blooms on mariculture and marine fisheries

    Get PDF
    Aquaculture is the fastest growing food sector globally and protein provisioning from aquaculture now exceeds that from wild capture fisheries. There is clear potential for the further expansion of marine aquaculture (mariculture), but there are associated risks. Some naturally occurring algae can proliferate under certain environmental conditions, causing deoxygenation of seawater, or releasing toxic compounds (phycotoxins), which can harm wild and cultured finfish and shellfish, and also human consumers. The impacts of these so‐called harmful algal blooms (HABs) amount to approximately 8 $billion/yr globally, due to mass mortalities in finfish, harvesting bans preventing the sale of shellfish that have accumulated unsafe levels of HAB phycotoxins and unavoided human health costs. Here, we provide a critical review and analysis of HAB impacts on mariculture (and wild capture fisheries) and recommend research to identify ways to minimise their impacts to the industry. We examine causal factors for HAB development in inshore versus offshore locations and consider how mariculture itself, in its various forms, may exacerbate or mitigate HAB risk. From a management perspective, there is considerable scope for strategic siting of offshore mariculture and holistic Environmental Approaches for Aquaculture, such as offsetting nutrient outputs from finfish farming, via the co‐location of extractive shellfish and macroalgae. Such pre‐emptive, ecosystem‐based approaches are preferable to reactive physical, chemical or microbiological control measures aiming to remove or neutralise HABs and their phycotxins. To facilitate mariculture expansion and long‐term sustainability, it is also essential to evaluate HAB risk in conjunction with climate change

    Bioavailability and kidney responses to Diclofenac in the fathead minnow (Pimephales promelas)

    Get PDF
    This is the author accepted manuscript. The final version is available from the publisher via the DOI in this record.Diclofenac is one of the most widely prescribed nonsteroidal anti-inflammatory drugs worldwide. It is frequently detected in surface waters; however, whether this pharmaceutical poses a risk to aquatic organisms is debated. Here we quantified the uptake of diclofenac by the fathead minnow (Pimephales promelas) following aqueous exposure (0.2-25.0 μg L(-1)) for 21 days, and evaluated the tissue and biomolecular responses in the kidney. Diclofenac accumulated in a concentration- and time-dependent manner in the plasma of exposed fish. The highest plasma concentration observed (for fish exposed to 25 μg L(-1) diclofenac) was within the therapeutic range for humans. There was a strong positive correlation between exposure concentration and the number of developing nephrons observed in the posterior kidney. Diclofenac was not found to modulate the expression of genes in the kidney associated with its primary mode of action in mammals (prostaglandin-endoperoxide synthases) but modulated genes associated with kidney repair and regeneration. There were no significant adverse effects following 21 days exposure to concentrations typical of surface waters. The combination of diclofenac's uptake potential, effects on kidney nephrons and relatively small safety margin for some surface waters may warrant a longer term chronic health effects analysis for diclofenac in fish.This work was funded by Knowledge Transfer Partnership (KTP): Use of ‘omic’ technologies in the environmental risk assessment of pharmaceuticals (KTP007650) and AstraZeneca’s Safety, Health and Environment (SHE) Research Programme. We thank Lina Gunnarsson, Matt Winter and James Cresswell (Exeter University), and former members of the Brixham Environmental Laboratory for their advice and assistance. Authors declare no competing financial interest

    Quantifying habitat provisioning at macroalgal cultivation sites.

    Get PDF
    Macroalgal cultivation is expanding rapidly, and promises to contribute significantly towards future food and energy security, sustainable livelihoods, ecosystem services and habitat provisioning for a range of associated organisms globally. Habitat provisioning underpins biodiversity and ecosystem structure and functioning, supports many ecosystem services and has possible benefits to other marine industries, including enhancement of commercial fish stocks. In macroalgal cultivation, however, only recently has habitat provisioning started to be assessed at a local scale (within a farm's footprint) and with a range of different approaches. This review evaluates techniques used to quantify habitat provisioning in and around macroalgal cultivation sites, for species ranging from microorganisms to megafauna, and outlines recommendations to enable a more comprehensive ecological valuation of macroalgal cultivation in the future. The majority of information on biodiversity associated with macroalgal cultivation is associated with quantifying biofouling or pest organisms, rather than the contribution of colonising species to healthy ecosystem functioning. We suggest how better monitoring of macroalgal cultivation could enable an ecosystem approach to aquaculture (EAA) in the future. To achieve this, we highlight the need for standardised and robust methods for quantifying habitat provisioning that will enable assessment and monitoring of macroalgal cultivation sites of varying scales and within different regions and environmental settings. Increased evidence for the potential habitat value of macroalgal cultivation sites will help inform and shape marine legislation, licencing and certification for macroalgal farmers and potentially reduce marine user conflicts, helping the industry to continue to grow sustainably using EAA

    Wholescape assessment of Water Quality status, drivers and impacts in the Exe Estuary Catchment and implications for ecosystem health and services including Shellfish Aquaculture

    Get PDF
    This is the author accepted manuscript. The final version is available from SWEEP via the URL in this recordThe appendices to this report are available in ORE at http://hdl.handle.net/10871/131805The specific aims of this investigation are to provide an assessment of the current water quality of the Exe Estuary catchment, including tributaries of the Exe Estuary (Figure 1), assessing the drivers for water quality impairment, and impacts of this on estuarine and coastal bivalve shellfish aquaculture (farming of mussels, oysters and clams). This was done through a detailed evaluation of publicly available data and information. The investigation follows a receptor-pathway-source approach to back-track from designated shellfish waters in Lyme Bay and the Exe Estuary to potential upstream sources of contaminants in the Exe Estuary catchment. When reviewing information on potential sources and drivers of water quality issues, we highlight where there are significant data gaps. This report also provides a summary of activities and actions already underway within the wider catchment designed to achieve water quality improvements and discusses potential future catchment management interventions.Natural Environment Research Council (NERC

    Minimizing experimental testing on fish for legacy pharmaceuticals.

    Get PDF
    This is the final version. Available from the American Chemical Society via the DOI in this record. There was no regulatory requirement for ecotoxicological testing of human pharmaceuticals authorized before 2006, and many of these have little or no data available to assess their environmental risk. Motivated by animal welfare considerations, we developed a decision tree to minimize in vivo fish testing for such legacy active pharmaceutical ingredients (APIs). The minimum no observed effect concentration (NOECmin, the lowest NOEC from chronic Daphnia and algal toxicity studies), the theoretical therapeutic water concentration (TWC, calculated using the fish plasma model), and the predicted environmental concentration (PEC) were used to derive API risk quotients (PEC/NOECmin and PEC/TWC). Based on a verification data set of 96 APIs, we show that by setting a threshold value of 0.001 for both risk quotients, the need for in vivo fish testing could potentially be reduced by around 35% without lowering the level of environmental protection. Hence, for most APIs, applying an assessment factor of 1000 (equivalent to the threshold of 0.001) to NOECmin substituted reliably for NOECfish, and TWC acted as an effective safety net for the others. In silico and in vitro data and mammalian toxicity data may further support the final decision on the need for fish testing.Innovative Medicines Initiative 2 Joint Undertakin
    corecore